Cellebrite DI Statistics
Total Valuation
Cellebrite DI has a market cap or net worth of $2.21 billion. The enterprise value is $1.92 billion.
Market Cap | 2.21B |
Enterprise Value | 1.92B |
Important Dates
The next confirmed earnings date is Thursday, May 23, 2024, before market open.
Earnings Date | May 23, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Cellebrite DI has 205.30 million shares outstanding. The number of shares has decreased by -2.68% in one year.
Shares Outstanding | 205.30M |
Shares Change (YoY) | -2.68% |
Shares Change (QoQ) | -4.83% |
Owned by Insiders (%) | 49.34% |
Owned by Institutions (%) | 42.48% |
Float | 55.89M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 33.85 |
PS Ratio | 6.80 |
Forward PS | 5.73 |
PB Ratio | 64.60 |
P/FCF Ratio | 23.48 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 44.42, with an EV/FCF ratio of 20.41.
EV / Earnings | n/a |
EV / Sales | 5.91 |
EV / EBITDA | 44.42 |
EV / EBIT | 57.80 |
EV / FCF | 20.41 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.41.
Current Ratio | 1.66 |
Quick Ratio | 1.50 |
Debt / Equity | 0.41 |
Debt / EBITDA | 0.33 |
Debt / FCF | 0.15 |
Interest Coverage | 0.31 |
Financial Efficiency
Return on equity (ROE) is -251.30%.
Return on Equity (ROE) | -251.30% |
Return on Assets (ROA) | -17.60% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $322,530 |
Profits Per Employee | -$80,456 |
Employee Count | 1,008 |
Asset Turnover | 0.70 |
Inventory Turnover | 5.29 |
Taxes
In the past 12 months, Cellebrite DI has paid $5.54 million in taxes.
Income Tax | 5.54M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +100.75% in the last 52 weeks. The beta is 1.53, so Cellebrite DI's price volatility has been higher than the market average.
Beta (1Y) | 1.53 |
52-Week Price Change | +100.75% |
50-Day Moving Average | 11.28 |
200-Day Moving Average | 8.76 |
Relative Strength Index (RSI) | 46.98 |
Average Volume (30 Days) | 953,122 |
Short Selling Information
The latest short interest is 2.59 million, so 1.26% of the outstanding shares have been sold short.
Short Interest | 2.59M |
Short Previous Month | 2.48M |
Short % of Shares Out | 1.26% |
Short % of Float | 4.64% |
Short Ratio (days to cover) | 2.42 |
Income Statement
In the last 12 months, Cellebrite DI had revenue of $325.11 million and -$81.10 million in losses. Loss per share was -$0.43.
Revenue | 325.11M |
Gross Profit | 271.88M |
Operating Income | 33.24M |
Pretax Income | -75.56M |
Net Income | -81.10M |
EBITDA | 43.25M |
EBIT | 33.24M |
Loss Per Share | -$0.43 |
Balance Sheet
The company has $302.92 million in cash and $14.13 million in debt, giving a net cash position of $288.79 million or $1.41 per share.
Cash & Cash Equivalents | 302.92M |
Total Debt | 14.13M |
Net Cash | 288.79M |
Net Cash Per Share | $1.41 |
Equity / Book Value | 34.21M |
Book Value Per Share | 0.17 |
Working Capital | 168.26M |
Cash Flow
In the last 12 months, operating cash flow was $102.06 million and capital expenditures -$7.92 million, giving a free cash flow of $94.14 million.
Operating Cash Flow | 102.06M |
Capital Expenditures | -7.92M |
Free Cash Flow | 94.14M |
FCF Per Share | $0.50 |
Margins
Gross margin is 83.63%, with operating and profit margins of 10.22% and -24.95%.
Gross Margin | 83.63% |
Operating Margin | 10.22% |
Pretax Margin | -23.24% |
Profit Margin | -24.95% |
EBITDA Margin | 13.30% |
EBIT Margin | 10.22% |
FCF Margin | 28.96% |
Dividends & Yields
Cellebrite DI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 2.68% |
Shareholder Yield | 2.68% |
Earnings Yield | -3.67% |
FCF Yield | 4.26% |
Analyst Forecast
The average price target for Cellebrite DI is $12.92, which is 19.30% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.92 |
Price Target Difference | 19.30% |
Analyst Consensus | Strong Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | 17.47% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Cellebrite DI has an Altman Z-Score of 4.16 and a Piotroski F-Score of 5.
Altman Z-Score | 4.16 |
Piotroski F-Score | 5 |